Medical Technology

@xconomy.com 4 years ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 4 years ago

MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests

@xconomy.com 4 years ago

As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing

@xconomy.com 5 years ago

FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea

@xconomy.com 5 years ago

With New Data, Intercept On Track for First-Ever Approved NASH Drug

@xconomy.com 5 years ago

Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B

@xconomy.com 5 years ago

With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy

@xconomy.com 5 years ago

Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms

@xconomy.com 5 years ago

No HQ2? No problem, Say Leaders in TX Cities Passed Over by Amazon

@xconomy.com 5 years ago

Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder

@xconomy.com 5 years ago

Six Life Science Firms Close Q3 with an IPO, More Are on the Way

@xconomy.com 5 years ago

TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW

@xconomy.com 5 years ago

With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care

@xconomy.com 5 years ago

Get Physical: Houston’s Kanthaka Offers Personal Trainers in an Hour

@xconomy.com 5 years ago

Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum